Simply Better Brands Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Simply Better Brands's earnings have been declining at an average annual rate of -55.8%, while the Pharmaceuticals industry saw earnings growing at 46% annually. Revenues have been growing at an average rate of 52.4% per year.
Anahtar bilgiler
-55.8%
Kazanç büyüme oranı
-98.4%
EPS büyüme oranı
Pharmaceuticals Sektör Büyümesi | 23.1% |
Gelir büyüme oranı | 52.4% |
Özkaynak getirisi | n/a |
Net Marj | -32.7% |
Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Simply Better Brands Corp. (CVE:SBBC) Soars 26% But It's A Story Of Risk Vs Reward
Jul 14Market Might Still Lack Some Conviction On Simply Better Brands Corp. (CVE:SBBC) Even After 43% Share Price Boost
May 21Is Simply Better Brands (CVE:SBBC) Using Debt Sensibly?
Mar 29Simply Better Brands Corp. (CVE:SBBC) Screens Well But There Might Be A Catch
Feb 02Further Upside For Simply Better Brands Corp. (CVE:SBBC) Shares Could Introduce Price Risks After 27% Bounce
Apr 17Calculating The Intrinsic Value Of PureK Holdings Corp. (CVE:PKAN)
Mar 10Gelir ve Gider Dağılımı
Simply Better Brands nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Jun 24 | 81 | -26 | 53 | 0 |
31 Mar 24 | 82 | -22 | 52 | 0 |
31 Dec 23 | 80 | -24 | 54 | 0 |
30 Sep 23 | 63 | -11 | 37 | 0 |
30 Jun 23 | 57 | -12 | 34 | 0 |
31 Mar 23 | 65 | -12 | 44 | 0 |
31 Dec 22 | 65 | -12 | 49 | 0 |
30 Sep 22 | 49 | -11 | 39 | 0 |
30 Jun 22 | 39 | -16 | 37 | 0 |
31 Mar 22 | 25 | -15 | 27 | 0 |
31 Dec 21 | 16 | -13 | 18 | 0 |
30 Sep 21 | 12 | -11 | 14 | 0 |
30 Jun 21 | 12 | -5 | 8 | 0 |
31 Mar 21 | 12 | -3 | 7 | 0 |
31 Dec 20 | 14 | -2 | 8 | 0 |
30 Sep 20 | 15 | 1 | 8 | 0 |
30 Jun 20 | 19 | 3 | 9 | 0 |
31 Mar 20 | 22 | 4 | 10 | 0 |
31 Dec 19 | 25 | 6 | 11 | 0 |
31 Dec 18 | 15 | 4 | 6 | 0 |
Kaliteli Kazançlar: SBBC is currently unprofitable.
Büyüyen Kar Marjı: SBBC is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: SBBC is unprofitable, and losses have increased over the past 5 years at a rate of 55.8% per year.
Büyüme Hızlandırma: Unable to compare SBBC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: SBBC is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-40.8%).
Özkaynak Getirisi
Yüksek ROE: SBBC's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.